Olgu Sunumu

Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria

Cilt: 10 Sayı: 04 15 Aralık 2020
  • Selma Bouheraoua
  • Farida Assaous
  • Nora Zourdani
  • Naima Tahrat
  • Hassiba Tali Maamar
PDF İndir
EN

Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria

Öz

We describe the emergence of plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19. The strain was isolated from a urine sample of a 75-year-old male patient. The identification was carried out by an automated system. The antibiogram was performed according to CLSI recommendations. The colistin MIC was determined by broth micro-dilution according to CA-SFM/EUCAST criteria. The detection of mcr-1 was carried out by immunochromatographic test and PCR mcr-1. Genetic transfers and determination of the plasmid incompatibility group were made. The ST was carried out by MLST using the Pasteur scheme. The strain has a high-level penicillinase resistance phenotype. It was susceptible to amikacin and resistant to gentamicin, tobramycin, fluoroquinolones, tetracycline, chloramphenicol, and cotrimoxazole. The strain was resistant to colistin (MIC ꞊ 4 μg/ml). The genetic transfer is given a colistin-resistant transconjugant. The plasmid carrying mcr-1 gene belongs to the incompatibility group IncHI2.The strain belongs to ST19. J Microbiol Infect Dis 2019; 10(4):222-224.

Anahtar Kelimeler

Kaynakça

  1. 1. Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases. févr 2016;16(2):161‑8.
  2. 2. Dortet L, Bonnin R, Jousset A, Gauthier L, Naas T. Émergence de la résistance à la colistine chez les entérobactéries : une brèche dans le dernier rempart contre la pan-résistance ! Journal des Anti-infectieux. déc 2016;18(4):139‑59.
  3. 3. CLSI. Performance standards for Antimicrobial Susceptibility testing. 28th ed. CLSI supplement M100.Wayne, PA: Clinical and Laboratory Standard Institute; 2018. (ISBN: 1-56238-839-8)
  4. 4. Enterobacteriaceae. In: CASFM / EUCAST: Société Française de Microbiologie Ed; 2018: p.36-43.
  5. 5. Chabou S, Leangapichart T, Okdah L, Le Page S, Hadjadj L, Rolain J-M. Real-time quantitative PCR assay with Taqman ® probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. N Microb N Infect 2016; 13:71‑4.
  6. 6. Jaureguy F, Landraud L, Passet V, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008;9 (1):560.
  7. 7. Bachiri T, Lalaoui R, Bakour S, et al. First Report of the Plasmid-Mediated Colistin Resistance Gene mcr-1 in Escherichia coli ST405 Isolated from Wildlife in Bejaia, Algeria. Microbial Drug Resist 2018; 24(7):890‑5.
  8. 8. Yanat B, Machuca J, Yahia RD, Touati A, Pascual Á, Rodríguez-Martínez J-M. First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. Intern J Antimicrob Agent 2016;48(6):760‑1.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Olgu Sunumu

Yazarlar

Selma Bouheraoua Bu kişi benim
Algeria

Farida Assaous Bu kişi benim
Algeria

Nora Zourdani Bu kişi benim
Algeria

Naima Tahrat Bu kişi benim
Algeria

Hassiba Tali Maamar Bu kişi benim
Algeria

Yayımlanma Tarihi

15 Aralık 2020

Gönderilme Tarihi

22 Aralık 2020

Kabul Tarihi

23 Ağustos 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 10 Sayı: 04

Kaynak Göster

APA
Bouheraoua, S., Assaous, F., Zourdani, N., Tahrat, N., & Maamar, H. T. (2020). Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases, 10(04), 222-224. https://doi.org/10.5799/jmid.839476
AMA
1.Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases. 2020;10(04):222-224. doi:10.5799/jmid.839476
Chicago
Bouheraoua, Selma, Farida Assaous, Nora Zourdani, Naima Tahrat, ve Hassiba Tali Maamar. 2020. “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10 (04): 222-24. https://doi.org/10.5799/jmid.839476.
EndNote
Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT (01 Aralık 2020) Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases 10 04 222–224.
IEEE
[1]S. Bouheraoua, F. Assaous, N. Zourdani, N. Tahrat, ve H. T. Maamar, “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”, Journal of Microbiology and Infectious Diseases, c. 10, sy 04, ss. 222–224, Ara. 2020, doi: 10.5799/jmid.839476.
ISNAD
Bouheraoua, Selma - Assaous, Farida - Zourdani, Nora - Tahrat, Naima - Maamar, Hassiba Tali. “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10/04 (01 Aralık 2020): 222-224. https://doi.org/10.5799/jmid.839476.
JAMA
1.Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases. 2020;10:222–224.
MLA
Bouheraoua, Selma, vd. “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases, c. 10, sy 04, Aralık 2020, ss. 222-4, doi:10.5799/jmid.839476.
Vancouver
1.Selma Bouheraoua, Farida Assaous, Nora Zourdani, Naima Tahrat, Hassiba Tali Maamar. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases. 01 Aralık 2020;10(04):222-4. doi:10.5799/jmid.839476